GeneCure Competitors and Similar CompaniesClear all
GeneCure's competitors and similar companies include Anagenics, ExtremoChem, Novozymes Berlin and Satellos Bioscience.
 GeneCure GeneCure Biotechnologies is a biotechnology company focused on developing its patented gene transfer technology for the treatment of various genetic diseases, infection disease, and cancers. |  Anagenics Anagenics (formerly known as Cellmid) is a life sciences company focused on age-related conditions. |  ExtremoChem ExtremoChem is a company that develops and commercializes small synthetic molecules for the stabilization of biologicals. |  Novozymes Berlin Novozymes Berlin (formerly known as OrganoBalance) is a biotechnology research and development company. |  Satellos Bioscience Satellos Bioscience is a biotechnology company developing medicines to treat degenerative muscle diseases. | |
Founding Date | Founding Date 1998 | Founding Date 2004 | Founding Date 2013 | Founding Date 2001 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Norcross, US HQ | Locations Sydney, AU HQ | Locations Lisboa, PT HQ | Locations Berlin, DE HQ | Locations Toronto, CA HQ |
Employees | Employees N/A | Employees N/A | Employees 5 | Employees 3 | Employees 234% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $5.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $2.7m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $2.5m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($1.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($24.9m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 2m (over 12 years ago) | Latest funding round N/A | Latest funding round $ 53.1k (over 9 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 2m | Total funding raised N/A | Total funding raised $ 53.1k | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Anagenics
HQ
Sydney, AU
Anagenics (formerly known as Cellmid) is a life sciences company focused on age-related conditions.
View companyExtremoChem
HQ
Lisboa, PT
Employees
5
ExtremoChem is a company that develops and commercializes small synthetic molecules for the stabilization of biologicals.
View companyNovozymes Berlin
HQ
Berlin, DE
Novozymes Berlin (formerly known as OrganoBalance) is a biotechnology research and development company.
View companySatellos Bioscience
HQ
Toronto, CA
Employees
23↓ 4% decrease
Satellos Bioscience is a biotechnology company developing medicines to treat degenerative muscle diseases.
View company